ExpressionMed Celebrates Diabetes Awareness Month With NFT Dragons, Donations & More
11 nov. 2021 14h37 HE
|
ExpressionMed
MINNEAPOLIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- What do dragons, NFTs, and medical tape have in common? They all work together to improve the lives of people living with diabetes. ExpressionMed,...
Innovation Zed Announce Non-Invasive Continuous Glucose Monitoring Project and Appointment of a New Researcher
11 oct. 2021 01h00 HE
|
Innovation Zed Ltd.
DUBLIN, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Innovation Zed Ltd., developer of novel diabetes technologies (the InsulCheck range), announced further advancement in their research of technologies for...
Nemaura Medical Announces Commercial Agreement with UK Licensee
27 sept. 2021 08h00 HE
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
21 sept. 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...
Supersapiens Welcomes Seven-Time Grand Tour Winner Chris Froome as Newest Advisor and Investor
09 sept. 2021 10h30 HE
|
Supersapiens
Atlanta, GA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Supersapiens, the world’s imminent energy management system for performance athletes, powered by the Abbott Libre Sense Glucose Sport Biosensor, is...
Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions
30 juin 2021 09h15 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
02 mars 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing
04 févr. 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Digital Diabetes Management Market revenue to cross USD 54 Bn by 2027: Global Market Insights, Inc.
25 janv. 2021 05h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Jan. 25, 2021 (GLOBE NEWSWIRE) -- According to latest report “Digital Diabetes Management Market by Product Type (Devices, , Services), Patient Type (Type 1, Type 2), End-Use...
Global Continuous Glucose Monitoring (CGM) Devices Market to Witness a CAGR of 12.4% during 2019-2025
02 mai 2019 06h34 HE
|
Energias Market Research
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- The global continuous glucose monitoring (CGM) devices market is expected to grow significantly from USD 529 million in 2018 to USD 1,263 million in 2025,...